Clinical Trials
10 trialsNCT05645653 2022-12-09
Nurse-led Medication Self-management Intervention in the Improvement of Medication Adherence
Hamad Medical Corporation
Phase NA Unknown
NCT02872298 2022-04-12
RELIEF-1
Nuvaira, Inc.
Phase NA Terminated
NCT01103037 2020-12-19
Efficacy, Safety and Pharmacokinetics of QAV680 Versus Placebo in Patients With Asthma
Novartis
Phase 2 Terminated
NCT03387241 2019-04-29
Efficacy of FLUTIFORM ® vs Seretide® in Moderate to Severe Persistent Asthma in Subjects Aged ≥12 Years
Mundipharma (China) Pharmaceutical Co. Ltd
Phase 3 Unknown
NCT02022761 2018-05-30
Safety, Tolerability and Pharmacokinetics of Inhaled Laninamivir Octanoate TwinCaps® DPI in Adults With Chronic Asthma
Vaxart
Phase 1 Completed
NCT00455923 2018-02-05
SERETIDE Vs FLIXOTIDE In Mild Persistent Asthma (GINAII)
GlaxoSmithKline
Phase 4 Completed
NCT02105012 2017-06-06
Study to Assess the Efficacy and Safety of Budesonide (PT008) in Adult Subjects With Mild to Moderate Persistent Asthma
Pearl Therapeutics, Inc.
Phase 2 Completed
NCT00461500 2017-03-03
SERETIDE 100/50 bd (Twice Daily) Versus FLIXOTIDE 100 bd As Initial Maintenance Therapy In Moderate Asthma In Adults
GlaxoSmithKline
Phase 4 Completed
NCT00646516 2011-01-24
Gemini Symbicort pMDI
AstraZeneca
Phase 3 Completed
NCT00141791 2009-08-07
Study Evaluating Etanercept in Moderate to Severe Asthma
Wyeth is now a wholly owned subsidiary of Pfizer
Phase 2 Completed